Brief: Nordic Nanovector H2 Comprehensive Loss Narrows To NOK 111 Mln
Feb 28 (Reuters) - Nordic Nanovector ASA NANOVN.OL :
* H2 REVENUES AMOUNTED TO NOK 0.0 MILLION VERSUS NOK 0.0
MILLION
YEAR AGO
* H2 COMPREHENSIVE LOSS AMOUNTED TO NOK 111 MILLION VERSUS
LOSS OF
NOK 237.6 MILLION YEAR AGO
Source text for Eikon: ID:nWkr1pqWzg
Further company coverage: NANOVN.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Thor Medical ASA
See all newsBrief: Thor Medical Enters Partnership Agreement With Minerva Imaging
Brief: Thor Medical Partners With Eckert & Ziegler
Brief: Thor Medical Completes Alphaone Production Facility At Herøya Industrial Park
Brief: Thor Medical Enters Multiyear Agreement With Node Pharma
Brief: Thor Medical H2 EBITDA Loss NOK 25.7 Mln